Exceptional response to anti-PD-1 treatment in a patient with metastatic cutaneous hidradenocarcinoma.
作者信息
Obermann H, Schmidle P, Steimle-Grauer S A, Pfarr N, Posch C
机构信息
Department of Dermatology and Allergy, School of Medicine, German Cancer Consortium (DKTK), Technical University of Munich, Germany.
Institute for Pathology, Technical University of Munich, Germany.
出版信息
Eur J Cancer. 2021 Mar;145:143-145. doi: 10.1016/j.ejca.2020.12.015. Epub 2021 Jan 16.
PMID:33465705
Abstract
摘要
相似文献
1
Exceptional response to anti-PD-1 treatment in a patient with metastatic cutaneous hidradenocarcinoma.一名转移性皮肤汗腺癌患者对抗PD-1治疗的卓越反应。
Eur J Cancer. 2021 Mar;145:143-145. doi: 10.1016/j.ejca.2020.12.015. Epub 2021 Jan 16.
2
Complete response of metastatic malignant hidradenocarcinoma to capecitabine treatment.转移性恶性汗腺癌对卡培他滨治疗的完全缓解。
Arch Dermatol. 2011 Aug;147(8):998-9. doi: 10.1001/archdermatol.2011.210.
3
Metastatic cutaneous apocrine adenocarcinoma responsive to the programmed cell death protein 1 inhibitor pembrolizumab.对程序性细胞死亡蛋白1抑制剂帕博利珠单抗有反应的转移性皮肤顶泌汗腺腺癌。
Eur J Cancer. 2018 Feb;90:146-148. doi: 10.1016/j.ejca.2017.11.008. Epub 2017 Dec 11.
4
Immune checkpoint blockade for patients with lung cancer and idiopathic pulmonary fibrosis.肺癌合并特发性肺纤维化患者的免疫检查点阻断治疗
Eur J Cancer. 2021 Mar;145:179-182. doi: 10.1016/j.ejca.2020.12.016. Epub 2021 Jan 22.
5
Clinical Application of Iodine-125 Seed Brachytherapy Combined with Anti-PD-1 Antibodies in the Treatment of Lung Cancer.碘-125 种子近距离放疗联合抗 PD-1 抗体在肺癌治疗中的临床应用。
Clin Ther. 2020 Aug;42(8):1612-1616. doi: 10.1016/j.clinthera.2020.05.018. Epub 2020 Jul 7.
6
Interesting response to concurrent chemoradiation in metastatic eccrine porocarcinoma.转移性小汗腺汗孔癌对同步放化疗的有趣反应。
J Dermatol. 2008 Sep;35(9):606-7. doi: 10.1111/j.1346-8138.2008.00533.x.
7
Complete Response of a Patient With Metastatic Sarcomatoid Renal Cell Carcinoma to a Programmed Death-1 Checkpoint Inhibitor.一名转移性肉瘤样肾细胞癌患者对程序性死亡-1检查点抑制剂完全缓解
J Oncol Pract. 2018 Aug;14(8):511-513. doi: 10.1200/JOP.18.00213. Epub 2018 Jun 19.
8
Immunotherapy-refractory, EGFR overexpressing metastatic porocarcinoma responding to cetuximab.对西妥昔单抗有反应的免疫治疗难治性、表皮生长因子受体过表达转移性汗孔癌
Eur J Cancer. 2021 Mar;146:84-86. doi: 10.1016/j.ejca.2021.01.012. Epub 2021 Feb 12.
9
A case of eccrine poroma treated with 5% imiquimod cream.1例用5%咪喹莫特乳膏治疗的小汗腺汗孔瘤。
J Dermatol. 2005 Aug;32(8):691-3. doi: 10.1111/j.1346-8138.2005.tb00827.x.
10
Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone.转移性葡萄膜黑色素瘤在单独接受抗 PD-1 治疗后进展，随后接受抗 CTLA-4 和抗 PD-1 联合治疗，获得持久缓解。
J Immunother Cancer. 2018 Feb 12;6(1):13. doi: 10.1186/s40425-018-0322-1.
引用本文的文献
1
Based on Immune Microenvironment and Genomic Status, Exploring Immunotherapy in Advanced Hidradenocarcinoma: A Retrospective Analysis.基于免疫微环境和基因组状态，探索晚期大汗腺癌的免疫治疗：一项回顾性分析。
Acta Derm Venereol. 2024 May 13;104:adv22146. doi: 10.2340/actadv.v104.22146.
2
Nodular hidradenocarcinoma of the forehead presenting as a lipoma: A case report with a review of literature.表现为脂肪瘤的前额结节性汗腺癌：一例病例报告并文献复习
Int J Surg Case Rep. 2022 Dec;101:107795. doi: 10.1016/j.ijscr.2022.107795. Epub 2022 Nov 23.
3
Current Treatment Options for Cutaneous Adnexal Malignancies.皮肤附件恶性肿瘤的现行治疗选择。
Curr Treat Options Oncol. 2022 May;23(5):736-748. doi: 10.1007/s11864-022-00971-3. Epub 2022 Mar 26.
Zotero 插件